Enbrel's cost can vary depending on factors such as insurance coverage, dosage, and location. The drug is prescribed for conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. The average retail price for Enbrel can be substantial, with some sources indicating prices in the thousands of dollars for a month's supply [1].
How much does Enbrel typically cost without insurance?
Without insurance, the out-of-pocket cost for Enbrel can be very high. Prices can range significantly, but a common figure cited for a 30-day supply is several thousand dollars, potentially exceeding $4,000 or more depending on the specific formulation and quantity [2].
Are there programs to help with Enbrel costs?
Yes, there are programs designed to lower the cost of Enbrel for eligible patients. Amgen, the manufacturer of Enbrel, offers patient assistance programs, including the Enbrel Savings Card, which can reduce co-pays for commercially insured patients [3]. For uninsured or underinsured patients, there are also options for financial assistance that may be available through Amgen or other charitable organizations.
How does Enbrel's price compare to other biologic drugs?
As a biologic medication, Enbrel is generally more expensive than traditional small-molecule drugs. Its cost is comparable to other TNF inhibitors and biologic treatments used for similar autoimmune conditions. For instance, other biologics used for rheumatoid arthritis can also have prices in the thousands of dollars per month [1].
When does Enbrel's patent expire?
The patent landscape for Enbrel is complex, involving multiple patents covering its composition, formulation, and methods of use. While key patents have expired or are nearing expiration, the exact expiry dates and the extent of their coverage can be subject to legal challenges and variations [4]. Information on specific patent expiries can be found on resources like DrugPatentWatch.com [4].
Are there biosimilar versions of Enbrel available?
As of now, there are no FDA-approved biosimilar versions of Enbrel in the United States. The development and approval of biosimilars are a lengthy process that depends on patent expirations and successful regulatory review. The absence of biosimilars contributes to the current pricing structure of Enbrel [4].
What are the potential side effects of Enbrel?
Common side effects of Enbrel can include injection site reactions, upper respiratory infections, headache, and rash. More serious risks involve an increased risk of infections, including serious bacterial infections and tuberculosis, as well as certain types of cancer. Patients are advised to discuss all potential risks with their healthcare provider [5].
How is Enbrel administered?
Enbrel is typically administered as a self-injection under the skin. It is available in pre-filled syringes, auto-injectors, and vials for reconstitution [6].
How effective is Enbrel for rheumatoid arthritis?
Enbrel is an effective treatment for reducing the signs and symptoms of moderate to severe rheumatoid arthritis, helping to slow joint damage and improve physical function [6].
What is the typical dosage of Enbrel?
The dosage of Enbrel varies depending on the condition being treated and the patient's weight. For rheumatoid arthritis, a common dose is 50 mg injected twice weekly, or 50 mg once weekly [6].
Where can I find more information about Enbrel's cost and access?
For detailed information regarding Enbrel's cost, savings programs, and patient assistance, consulting the official Enbrel website and speaking with a healthcare provider or pharmacist is recommended. Resources like DrugPatentWatch.com offer insights into the patent status and potential market entries of biosimilars [4].
---
Sources
1. https://www.drugpatentwatch.com/enbrel/market-analysis
2. https://www.drugpatentwatch.com/enbrel/cost
3. https://www.drugpatentwatch.com/enbrel/patient-assistance
4. https://www.drugpatentwatch.com/enbrel/patent-expiry
5. https://www.drugpatentwatch.com/enbrel/side-effects
6. https://www.drugpatentwatch.com/enbrel/dosage